Merit Medical Systems Inc (OQ:MMSI)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
See Regulatory Filings on SEC
Company Contact
Address: 1600 West Merit Park Way
Tel: 1-44-32130509
IR: See website
Key People
Fred P. Lampropoulos
Chairman of the Board, Chief Executive Officer
Joseph C. Wright
Raul Parra
Chief Financial Officer, Treasurer
Neil Peterson
Chief Operating Officer
Michel J. Voigt
Chief Human Resource Officer
Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Business Overview
Merit Medical Systems, Inc. designs, develops, manufactures, markets and sells medical products for interventional and diagnostic procedures. The Company is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions and original equipment manufacturer. Within these product categories, it sells a variety of products, including cardiology and radiology devices, as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care and others. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.
Financial Overview
For the three months ended 31 March 2024, Merit Medical Systems Inc revenues increased 9% to $323.5M. Net income increased 36% to $28.2M. Revenues reflect Cardiovascular segment increase of 9% to $313.4M, Endoscopy segment increase of 6% to $10.1M, United States segment increase of 9% to $186.1M, International segment increase of 9% to $137.4M. Net income benefited from Cardiovascular segment income increase of 37% to $32.9M.
Employees: 6,950 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $4,971M as of Mar 31, 2024
Annual revenue (TTM): $1,283M as of Mar 31, 2024
EBITDA (TTM): $231.70M as of Mar 31, 2024
Net annual income (TTM): $101.95M as of Mar 31, 2024
Free cash flow (TTM): $130.63M as of Mar 31, 2024
Net Debt Last Fiscal Year: $218.22M as of Mar 31, 2024
Shares outstanding: 58,105,654 as of Apr 26, 2024
Index Membership: S&P 600 Small Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.